Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2011

01-01-2011 | Original Article

Peripheral Arthritis in the Course of Inflammatory Bowel Diseases

Authors: İlhami Yüksel, Hilmi Ataseven, Ömer Başar, Seyfettin Köklü, İbrahim Ertuğrul, Aysel Ülker, Ülkü Dağlı, Nurgül Şaşmaz

Published in: Digestive Diseases and Sciences | Issue 1/2011

Login to get access

Abstract

Background

Musculoskeletal disorders are well-defined extra-intestinal manifestations of inflammatory bowel diseases (IBD). There is little data regarding the frequencies of IBD and extra-intestinal manifestations from Central and East Europe and Middle Eastern countries.

Aims

To determine the prevalence of peripheral arthritis in IBD and to document the relationship to other extra-intestinal manifestations.

Methods

Enrolled in the study were 357 patients who were diagnosed with IBD from December 2002 through January 2008. All of the patients underwent a detailed whole-body examination by a gastroenterologist and rheumatologist.

Results

IBD-related peripheral arthritis (IBDPA) was found in 66 (18.5%) of the 357 patients (28.3% Crohn’s disease, 13.5% ulcerative colitis; p = 0.001 χ = 11.62). IBDPA was more frequent in female patients (60.6 vs. 39.4%, p = 0.000, χ = 11.12). In eight (12.1%) cases, IBDPA occurred before the onset of IBD. Acute self-limiting episodes, recurrences of the attacks, and persistent symptoms of arthritis were present in 40 (60.6%), 26 (39.3%), and 29 (45.7%) patients, respectively. Arthritis was symmetrical in 33 (50%) cases. Knees (65.2%) and ankles (62.1%) were the most commonly affected joints. Erythema nodosum and pyoderma gangrenosum were more common among patients with IBDPA than patients without it (p = 0.001, χ = 10.49, and p = 0.000 χ = 25.77, respectively).

Conclusions

IBDPA is a frequent extra-intestinal complication of IBD. Those of female gender and the presence of Crohn’s disease, erythema nodosum and pyoderma gangrenosum have a higher risk to develop IBDPA.
Literature
1.
go back to reference Salvarani C, Fornaciari G, Beltrami M, Macchioni PL. Musculoskeletal manifestations in inflammatory bowel disease. Eur J Intern Med. 2000;11:210–214.CrossRefPubMed Salvarani C, Fornaciari G, Beltrami M, Macchioni PL. Musculoskeletal manifestations in inflammatory bowel disease. Eur J Intern Med. 2000;11:210–214.CrossRefPubMed
2.
go back to reference Gran JT, Husby G. Joint manifestations in gastrointestinal diseases. 1. Pathophysiological aspects, ulcerative colitis and Crohn’s disease. Dig Dis. 1992;10:274–294.CrossRefPubMed Gran JT, Husby G. Joint manifestations in gastrointestinal diseases. 1. Pathophysiological aspects, ulcerative colitis and Crohn’s disease. Dig Dis. 1992;10:274–294.CrossRefPubMed
3.
go back to reference Turkcapar N, Toruner M, Soykan I, et al. The prevalence of extra-intestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int. 2006;2:663–668.CrossRef Turkcapar N, Toruner M, Soykan I, et al. The prevalence of extra-intestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int. 2006;2:663–668.CrossRef
4.
go back to reference Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut. 1998;42:387–391.CrossRefPubMed Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut. 1998;42:387–391.CrossRefPubMed
5.
go back to reference Salvarani C, Vlachonikolis IG. van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M, Olivieri I, Di Gennaro F, Politi P, Stockbrugger RW, Russel MG; European Collaborative IBD Study Group. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol. 2001;36:1307–1313.CrossRefPubMed Salvarani C, Vlachonikolis IG. van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M, Olivieri I, Di Gennaro F, Politi P, Stockbrugger RW, Russel MG; European Collaborative IBD Study Group. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol. 2001;36:1307–1313.CrossRefPubMed
6.
go back to reference Palm O, Moum B, Jahnsen J, Gran JT. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology (Oxford). 2001;40:1256–1261.CrossRef Palm O, Moum B, Jahnsen J, Gran JT. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology (Oxford). 2001;40:1256–1261.CrossRef
7.
go back to reference De Vos M, De Keyser F, Mielants H, Cuvelier C, Veys E. Review article: bone and joint diseases in inflammatory bowel disease. Aliment Pharmacol Ther. 1998;12:397–404.CrossRefPubMed De Vos M, De Keyser F, Mielants H, Cuvelier C, Veys E. Review article: bone and joint diseases in inflammatory bowel disease. Aliment Pharmacol Ther. 1998;12:397–404.CrossRefPubMed
8.
go back to reference Mielants H, Veys EM, Goethals K, Van Der Straeten C, Ackerman C. Destructive lesions of small joints in seronegative spondyloarthropathies relation to gut inflammation. Clin Exp Rheumatol. 1990;8:23–27.PubMed Mielants H, Veys EM, Goethals K, Van Der Straeten C, Ackerman C. Destructive lesions of small joints in seronegative spondyloarthropathies relation to gut inflammation. Clin Exp Rheumatol. 1990;8:23–27.PubMed
9.
go back to reference Tozun N, Atug O, Imeryuz N, et al. Yurdaydin C; Members of the Turkish IBD Study Group. Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey. J Clin Gastroenterol. 2009;43:51–57.CrossRefPubMed Tozun N, Atug O, Imeryuz N, et al. Yurdaydin C; Members of the Turkish IBD Study Group. Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey. J Clin Gastroenterol. 2009;43:51–57.CrossRefPubMed
10.
go back to reference Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996;23:29–34.CrossRefPubMed Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996;23:29–34.CrossRefPubMed
11.
go back to reference Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine. 1976;55:401–412.CrossRefPubMed Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine. 1976;55:401–412.CrossRefPubMed
12.
go back to reference Calin A, Fries JF. An “experimental” epidemic of Reiter’s syndrome revisited. Ann Intern Med. 1976;84:564–566.PubMed Calin A, Fries JF. An “experimental” epidemic of Reiter’s syndrome revisited. Ann Intern Med. 1976;84:564–566.PubMed
13.
go back to reference Schorr-Lesnick B, Brandt LJ. Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol. 1988;83:216–223.PubMed Schorr-Lesnick B, Brandt LJ. Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol. 1988;83:216–223.PubMed
14.
15.
go back to reference Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. National cooperative Crohn’s disease study: extraintestinal manifestations and perianal complications. Gastroenterology. 1979;77:914–920.PubMed Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. National cooperative Crohn’s disease study: extraintestinal manifestations and perianal complications. Gastroenterology. 1979;77:914–920.PubMed
16.
go back to reference Haslock I, Wright V. The musculo-squeletal complications of Crohn’s disease. Medicine. 1973;52:217–225.CrossRefPubMed Haslock I, Wright V. The musculo-squeletal complications of Crohn’s disease. Medicine. 1973;52:217–225.CrossRefPubMed
17.
go back to reference Yüksel I, Başar O, Ataseven H, et al. Mucocutaneous manifestations in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:546–550.CrossRefPubMed Yüksel I, Başar O, Ataseven H, et al. Mucocutaneous manifestations in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:546–550.CrossRefPubMed
Metadata
Title
Peripheral Arthritis in the Course of Inflammatory Bowel Diseases
Authors
İlhami Yüksel
Hilmi Ataseven
Ömer Başar
Seyfettin Köklü
İbrahim Ertuğrul
Aysel Ülker
Ülkü Dağlı
Nurgül Şaşmaz
Publication date
01-01-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1260-z

Other articles of this Issue 1/2011

Digestive Diseases and Sciences 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine